AIntibody: an experimentally validated in silico antibody discovery design challenge.

Competing Interests: Competing interests L.S., F.F., R.D., T.J.P., K.P.-S., S.D., M.F.E. and A.R.M.B. are employees of Specifica, an IQVIA business. O.H., C.L.-L. and Y.Q. are employees of Sanofi. H.G.N. and K.R. are employees of Incyte and stockholders. M. Shahsavarian is an employee of Eli Lilly. D.B. is an employee of Carterra. R.W. is an employee of Bonito Biosciences. C.M.D. discloses membership of the Scientific Advisory Board of Fusion Antibodies and AI proteins. P.M.T. is a member of the scientific advisory board for Nabla Bio, Aureka Biotechnologies, and Dualitas Therapeutics. P.M., E.V. and R.A. are employees of Novo Nordisk A/S. J.S. is an employee of OpenEye, Cadence Molecular Sciences. R.C.W. is an employee of AstraZeneca. A.E. and C.S. are employees of Merck Healthcare KGaA. S.B. is an employee of Evolutionary Scale. J.R. is an employee of Profluent Bio. S.F. is an employee of Alloy Therapeutics. V.B.K., S.M. and S.K. are employees of Takeda. P.K. is an employee of Cradle Bio. J.C.A. is an employee of GlobalBio. E.F., M. Stanton and C.P.G. are employees of Mosaic Biosciences. S.D.V. and F.T. are employees of Bayer A.G. All other authors declare no competing interests.